A clinical trial in 2015 linked an undisclosed GLP-1 to significant improvements in OSA severity, while a 2016 clinical trial found that weight loss resulting from liraglutide was significantly associated with a reduction in the apnea-hypopnea index (AHI)
We test, identify, and treat the root cause
Compounded medicines are prepared using the same active ingredient as the brand-name drugs
space consumption by at least 24 hours when possible
Body Weight Reduction in Women Treated with Tirzepatide by Reproductive Stage: A Post Hoc Analysis from the SURMOUNT Program. Obesity , vol
Patients with a history of eating disorders, seizures, uncontrolled hypertension, or current use of opioid medications should avoid Contrave due to contraindications and safety concerns